Сравнение
Epitalon vs. Pasireotid
Два пептида рядом — идентичность, доказательная база, правовой статус и известные нежелательные явления.
Идентичность
Категория
Исследования (прочее)
Исследования (прочее)
Номер CAS
307297-39-8
396091-73-9
Молекулярная масса
390.35 g/mol
1047.21 g/mol
Период полувыведения
0.3 h
нет данных
Последовательность
Ala-Glu-Asp-Glyнет данных
Механизм действия
Epitalon
Postulated mechanisms include modulation of gene expression in pinealocytes, telomerase activation (observed in cell culture studies) and influence on melatonin synthesis. A defined primary receptor is not established; the mechanistic basis rests on in-vitro and animal data from the Khavinson group.
Pasireotid
Pasireotide binds more broadly than older somatostatin analogs (SSTR1/2/3/5) with particularly high affinity for SSTR5. This suppresses, among others, ACTH release in Cushing's disease and GH release in acromegaly.
Доказательная база
Наивысшая доказательность
Исследование на людях
РКИ на людях
Исследования
4
1
из них на людях
1
1
Зафиксированные эффекты
4
2
Открытые противоречия
1
0
Задокументированные нежелательные явления
1
2
Правовой статус
Полные записи
Frequently asked questions
- What is the difference between Epitalon and Pasireotid?
- Epitalon is classified as "Исследования (прочее)", while Pasireotid is classified as "Исследования (прочее)". Epitalon: Synthetic tetrapeptide (Ala-Glu-Asp-Gly) derived from the pineal extract epithalamin (V. Khavinson, St. Petersburg). Investigated in the Russian research and anti-ageing context; Western controlled trials are largely absent. No medicines approval in EU or US. Pasireotid: Pasireotide is a multireceptor somatostatin analog binding to four of the five somatostatin receptors (especially SSTR5). It is approved for Cushing's disease and acromegaly. This page contrasts both neutrally and source-based — with no usage or dosing recommendation.
- Which peptide is better supported by science, Epitalon or Pasireotid?
- The highest available evidence level is "Исследование на людях" for Epitalon and "РКИ на людях" for Pasireotid. A higher evidence level means more robust data, but says nothing about suitability for an individual. The full body of evidence is on each peptide's own page.
- What is the legal status of Epitalon and Pasireotid in Germany and the United States?
- Германия: Epitalon — Не одобрено, Pasireotid — Рецептурный. США: Epitalon — Не одобрено, Pasireotid — Рецептурный. These are factual summaries with source and review date on the individual pages.